Cannabis Global Inc.'s ability to collect accounts receivable sequentially worsen to 8.71, indicating more challenging environment then in the second quarter 2022, but still, it is a far cry from any concerns. Cannabis Global's Accounts Receivable average collection period in the May 31 2022 quarter, has increased to 42 days, from 38 days, in the Feb 28 2022 quarter.

If we take a look into Healthcare sector 404 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending May 31 2022 from 2849 to 2851.

What is Receivable Turnover Ratio?
What is Cannabis Global Inc. Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CBGL Receivables Turnover Ratio	(May 31 2022) III. Quarter	(Feb 28 2022) II. Quarter	(Nov 30 2021) I. Quarter	(Aug 31 2021) IV. Quarter	(May 31 2021) III. Quarter
Y / Y Receivable Change	12.91 %	106.79 %	28669.63 %	-	697.33 %
Y / Y Revenue Change	-15.75 %	2330.24 %	12473.11 %	-	4662.03 %
Receivable Turnover Ratio (TTM)	8.71	9.57	9.38	9.26	6.7
CBGL's Total Ranking	# 2851	# 2849	# 87	# 1224	#
Accounts Receivable average collection period days	42	38	39	39	54
Seq. Receivable Change	-10.29 %	93.78 %	105.54 %	-68.4 %	64.31 %
Seq. Revenue Change	26.3 %	10.15 %	-9.62 %	-32.99 %	3543.09 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 31
Healthcare Sector	# 405
Overall Market	# 2851

Receivable Turnover Ratio Statistics
High	Average	Low
0.27	0.19	0.01
(May 31 2022)		(Feb 28 2021)

CBGL Company Profile • Back to CBGL Efficiency Comparisons • Compare CBGL Receivables Turnover Ratio to its Competitors

Financial Statements
Cannabis Global's Accounts Receivable	$ 0 Millions	Visit CBGL's Balance sheet
Cannabis Global's Sales TTM	$ 3 Millions	Visit CBGL's Income Statement
Sources of CBGL's Revenues		Visit CBGL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CBGL's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CBGL's Growth Rates	CBGL's Roa	CBGL's Inventory Turnover Ratio	CBGL's Dividend Comparisons
CBGL's Profitability Ratios	CBGL's Roi	CBGL's Asset Turnover Ratio	CBGL's Dividend Growth
CBGL's Valuation Ratios	CBGL's Roe	CBGL's Financial Strength Ratios	CBGL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending May 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending May 31 2022	Receivable at quarter ending May 31 2022
Qhslab Inc	17.17	$ 1.361 Millions	$ 0.079 Millions
Ngm Biopharmaceuticals Inc	17.06	$ 68.775 Millions	$ 4.031 Millions
Chemed Corporation	16.90	$ 2,151.852 Millions	$ 127.321 Millions
Histogen Inc	16.82	$ 4.356 Millions	$ 0.259 Millions
Statera Biopharma Inc fka Cytocom Inc	16.68	$ 3.254 Millions	$ 0.195 Millions
Electrocore Inc	16.48	$ 7.034 Millions	$ 0.427 Millions
Sangamo Therapeutics Inc	16.00	$ 114.158 Millions	$ 7.134 Millions
Finch Therapeutics Group Inc	15.89	$ 12.864 Millions	$ 0.810 Millions
Ethema Health Corporation	15.72	$ 3.917 Millions	$ 0.249 Millions
Neurometrix Inc	15.26	$ 8.325 Millions	$ 0.545 Millions
Travere Therapeutics Inc	14.98	$ 228.120 Millions	$ 15.224 Millions
Nutriband Inc	14.75	$ 1.709 Millions	$ 0.116 Millions
Patterson Companies Inc	14.51	$ 6,407.794 Millions	$ 441.616 Millions
Sonendo Inc	14.40	$ 37.358 Millions	$ 2.595 Millions
Arcturus Therapeutics Holdings Inc	14.33	$ 40.568 Millions	$ 2.830 Millions
Corcept Therapeutics Inc	14.32	$ 392.027 Millions	$ 27.369 Millions
C4 Therapeutics Inc	14.26	$ 50.066 Millions	$ 3.511 Millions
Thorne Healthtech Inc	14.10	$ 110.736 Millions	$ 7.854 Millions
Apellis Pharmaceuticals Inc	14.07	$ 96.643 Millions	$ 6.868 Millions
Myovant Sciences Ltd	13.95	$ 306.401 Millions	$ 21.961 Millions
Immutep Limited	13.63	$ 6.758 Millions	$ 0.496 Millions
4d Molecular Therapeutics Inc	13.55	$ 2.839 Millions	$ 0.210 Millions
Regenxbio Inc	13.55	$ 484.295 Millions	$ 35.744 Millions
Chinook Therapeutics Inc	13.48	$ 54.355 Millions	$ 4.034 Millions
Inhibrx Biosciences Inc	13.40	$ 7.028 Millions	$ 0.525 Millions
Talphera Inc	13.36	$ 2.876 Millions	$ 0.215 Millions
Affimed N v	13.24	$ 7.778 Millions	$ 0.587 Millions
Cv Sciences Inc	13.14	$ 18.661 Millions	$ 1.420 Millions
Nurix Therapeutics Inc	12.90	$ 38.701 Millions	$ 3.000 Millions
Clene Inc	12.79	$ 0.374 Millions	$ 0.029 Millions

Date modified: 2026-06-22T14:32:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.